Clinical Research Directory
Browse clinical research sites, groups, and studies.
New York City Observational Study of Mpox Immunity
Sponsor: NYU Langone Health
Summary
The goal of this study is to assess the immune response, tolerance, and safety of the low-dose intradermal (forearm) mpox vaccine in people who are HIV+ compared to people who are HIV-, and compared to the standard-dose subcutaneous (upper arm) vaccine. The resulting data will fill knowledge gaps, inform public health practices, and address community concerns about the absence of data for low-dose intradermal mpox vaccinations in people living with HIV.
Official title: New York City Observational Study of Mpox Immunity: NYC OSMI
Key Details
Gender
All
Age Range
18 Years - 100 Years
Study Type
OBSERVATIONAL
Enrollment
174
Start Date
2022-11-11
Completion Date
2026-06
Last Updated
2025-10-30
Healthy Volunteers
Yes
Locations (1)
NYU Langone Health
New York, New York, United States